EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep learning‐assisted design of nanozyme for immune regulation

Ke Chen, Si Sun, Shaofang Zhang, Huanhuan Qiao

Journal of Intelligent Medicine · 2026-09 · 3 (3) · 250-276

DOI: 10.1002/jim4.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Intelligent Medicine, online erschienen am 03.06.2026. Verfasst von Ke Chen und 3 weiteren Autor:innen. Die Arbeit nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipality, China Postdoctoral Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD), with rising global incidence and disease burden, is a multifactorial disorder characterized by chronic and relapsing gastrointestinal inflammation. Its pathogenesis involves immune dysregulation, reactive oxygen species bursts, and microbiota imbalance. Intestinal immune dysregulation drives IBD progression, making precise immune regulation essential for controlling inflammation and improving long‐term outcomes. Despite advances in clinical therapeutics such as corticosteroids and biologics, durable remission remains difficult due to limited targeting and side effects. Nanozymes have emerged as a promising treatment strategy for IBD owing to their structural stability, tunable catalytic performance, and capacity to regulate oxidative stress and inflammation. Deep learning (DL)‐assisted nanozyme engineering facilitates precise matching of catalytic activity and environmental responsiveness to the complex and dynamic inflammatory microenvironment of IBD, thereby enhancing immune regulation and therapeutic efficacy. In this review, we summarize recent advances in nanozyme‐based strategies for IBD, with an emphasis on DL‐assisted design and functional optimization. We discuss current challenges and future perspectives for nanozyme therapeutics, including biosafety evaluation and clinical translation toward precision management of IBD.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin Municipality
  • China Postdoctoral Science Foundation

Zitieren

APA

Chen, K., Sun, S., Zhang, S., & Qiao, H. (2026). Deep learning‐assisted design of nanozyme for immune regulation. Journal of Intelligent Medicine, 3(3), 250-276. https://doi.org/10.1002/jim4.70044

Vancouver

Chen K, Sun S, Zhang S, Qiao H. Deep learning‐assisted design of nanozyme for immune regulation. Journal of Intelligent Medicine. 2026;3(3):250-276. doi:10.1002/jim4.70044

BibTeX
@article{Chen2026,
  author = {Chen, Ke and Sun, Si and Zhang, Shaofang and Qiao, Huanhuan},
  title = {Deep learning‐assisted design of nanozyme for immune regulation},
  journal = {Journal of Intelligent Medicine},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {250--276},
  doi = {10.1002/jim4.70044}
}
Kostenlos starten →